Aspira Womens Health Stock Five Year Return
| AWHDelisted Stock | USD 0.03 0 10.30% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Aspira Womens' long-term financial health and intrinsic value.
Aspira |
Aspira Womens Health Company Five Year Return Analysis
Aspira Womens' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Aspira Womens Five Year Return | 2.10 % |
Most of Aspira Womens' fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspira Womens Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Aspira Womens Health has a Five Year Return of 2.1%. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The five year return for all United States stocks is notably lower than that of the firm.
Aspira Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aspira Womens' direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aspira Womens could also be used in its relative valuation, which is a method of valuing Aspira Womens by comparing valuation metrics of similar companies.Aspira Womens is currently under evaluation in five year return category among its peers.
Aspira Fundamentals
| Return On Equity | -7.23 | |||
| Return On Asset | -1.73 | |||
| Profit Margin | (1.43) % | |||
| Operating Margin | (1.46) % | |||
| Current Valuation | 3.93 M | |||
| Shares Outstanding | 35.22 M | |||
| Shares Owned By Insiders | 14.62 % | |||
| Shares Owned By Institutions | 4.13 % | |||
| Number Of Shares Shorted | 252.93 K | |||
| Price To Earning | 16.82 X | |||
| Price To Book | 5.02 X | |||
| Price To Sales | 0.31 X | |||
| Revenue | 9.18 M | |||
| Gross Profit | 5.48 M | |||
| EBITDA | (16.19 M) | |||
| Net Income | (13.09 M) | |||
| Cash And Equivalents | 20.48 M | |||
| Cash Per Share | 0.18 X | |||
| Total Debt | 2.76 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 3.26 X | |||
| Book Value Per Share | (0.15) X | |||
| Cash Flow From Operations | (12.11 M) | |||
| Short Ratio | 0.02 X | |||
| Earnings Per Share | (0.93) X | |||
| Target Price | 5.5 | |||
| Number Of Employees | 66 | |||
| Beta | 2.01 | |||
| Market Capitalization | 2.89 M | |||
| Total Asset | 5.49 M | |||
| Retained Earnings | (531.4 M) | |||
| Working Capital | (1.28 M) | |||
| Current Asset | 13.53 M | |||
| Current Liabilities | 4.13 M | |||
| Five Year Return | 2.10 % | |||
| Net Asset | 5.49 M |
About Aspira Womens Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aspira Womens Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aspira Womens using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aspira Womens Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Aspira Stock
If you are still planning to invest in Aspira Womens Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aspira Womens' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges |